THIRD HARMONIC BIO INC (THRD)

US88427A1079 - Common Stock

12.105  -2.22 (-15.53%)

After market: 12.105 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

THIRD HARMONIC BIO INC

NASDAQ:THRD (11/4/2024, 8:00:00 PM)

After market: 12.105 0 (0%)

12.105

-2.22 (-15.53%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month1.72%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap497.52M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

THRD Daily chart

Company Profile

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. The company is headquartered in San Francisco, California and currently employs 31 full-time employees. The company went IPO on 2022-09-15. The firm is focused on advancing the next wave of medicine for inflammatory diseases through the development of novel, small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. The company is developing medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. Mast cells are a part of the immune system, and dysfunctional mast cell activity has been implicated in the pathophysiology of a broad range of inflammatory disorders including urticaria, asthma and gastrointestinal disorders, among others. The firm is advancing its lead product candidate, THB335, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway and gastrointestinal tract. THB335 is a potent, highly selective, oral small molecule KIT inhibitor with a promising preclinical product profile.

Company Info

THIRD HARMONIC BIO INC

1700 Montgomery Street, Suite 210

San Francisco CALIFORNIA

P: 12097272457

Employees: 42

Website: https://thirdharmonicbio.com/

THRD News

ChartMill News Image13 hours ago - ChartmillWhat's going on in today's session

Let's have a look at the top gainers and losers in the middle of the day of today's session.

News Image6 days ago - Market News VideoInteresting THRD Call Options For May 2025
News Image2 months ago - Third Harmonic BioThird Harmonic Bio to Participate in Upcoming Investor Conferences in September
News Image2 months ago - Third Harmonic BioThird Harmonic Bio to Participate in Upcoming Investor Conferences in September

SAN FRANCISCO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on...

News Image2 months ago - Third Harmonic BioThird Harmonic Bio to Participate in Upcoming Investor Conferences
News Image2 months ago - Third Harmonic BioThird Harmonic Bio to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing...

THRD Twits

Here you can normally see the latest stock twits on THRD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example